• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Effect of periodontal treatments on blood pressure.牙周治疗对血压的影响。
Cochrane Database Syst Rev. 2021 Dec 12;12(12):CD009409. doi: 10.1002/14651858.CD009409.pub2.
2
Full-mouth treatment modalities (within 24 hours) for periodontitis in adults.成人牙周炎的全口治疗方法(24 小时内)。
Cochrane Database Syst Rev. 2022 Jun 28;6(6):CD004622. doi: 10.1002/14651858.CD004622.pub4.
3
Replacing salt with low-sodium salt substitutes (LSSS) for cardiovascular health in adults, children and pregnant women.用低钠盐替代物(LSSS)代替盐以促进成年人、儿童和孕妇的心血管健康。
Cochrane Database Syst Rev. 2022 Aug 10;8(8):CD015207. doi: 10.1002/14651858.CD015207.
4
Periodontal therapy for primary or secondary prevention of cardiovascular disease in people with periodontitis.牙周炎患者牙周病的一级或二级预防的牙周治疗。
Cochrane Database Syst Rev. 2022 Oct 4;10(10):CD009197. doi: 10.1002/14651858.CD009197.pub5.
5
Physical activity for treatment of irritable bowel syndrome.体力活动治疗肠易激综合征。
Cochrane Database Syst Rev. 2022 Jun 29;6(6):CD011497. doi: 10.1002/14651858.CD011497.pub2.
6
Rho kinase inhibitor for primary open-angle glaucoma and ocular hypertension.Rho 激酶抑制剂治疗原发性开角型青光眼和高眼压症。
Cochrane Database Syst Rev. 2022 Jun 10;6(6):CD013817. doi: 10.1002/14651858.CD013817.pub2.
7
Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults.基于手机的干预措施,用于提高成年人心血管疾病一级预防中所开药物的依从性。
Cochrane Database Syst Rev. 2018 Jun 22;6(6):CD012675. doi: 10.1002/14651858.CD012675.pub2.
8
Silicone gel sheeting for treating hypertrophic scars.硅凝胶片治疗增生性瘢痕。
Cochrane Database Syst Rev. 2021 Sep 26;9(9):CD013357. doi: 10.1002/14651858.CD013357.pub2.
9
Acupuncture for treating overactive bladder in adults.针刺治疗成人膀胱过度活动症。
Cochrane Database Syst Rev. 2022 Sep 23;9(9):CD013519. doi: 10.1002/14651858.CD013519.pub2.
10
Intravenous versus inhalational maintenance of anaesthesia for postoperative cognitive outcomes in elderly people undergoing non-cardiac surgery.非心脏手术老年患者术后认知结局:静脉麻醉维持与吸入麻醉维持的比较
Cochrane Database Syst Rev. 2018 Aug 21;8(8):CD012317. doi: 10.1002/14651858.CD012317.pub2.

引用本文的文献

1
Oral microbiome contributions to metabolic syndrome pathogenesis.口腔微生物群对代谢综合征发病机制的影响。
Front Microbiol. 2025 Aug 8;16:1630828. doi: 10.3389/fmicb.2025.1630828. eCollection 2025.
2
Effects of Periodontal Therapy on Cardiovascular Risk Biomarkers: A Systematic Review.牙周治疗对心血管风险生物标志物的影响:一项系统评价。
Oral Health Prev Dent. 2025 Aug 22;23:457-467. doi: 10.3290/j.ohpd.c_2173.
3
Correlation between endo-perio lesions and systemic diseases: A cross-sectional study.牙髓-牙周联合病变与全身疾病的相关性:一项横断面研究。
Bioinformation. 2025 May 31;21(5):1144-1148. doi: 10.6026/973206300211144. eCollection 2025.
4
Physicians' incentives, patients' characteristics, and quality of care: a systematic experimental comparison of performance-pay systems.医生的激励措施、患者特征与医疗质量:绩效薪酬制度的系统实验比较
Int J Health Econ Manag. 2025 Mar 19. doi: 10.1007/s10754-025-09390-x.
5
Changes in Serum Inflammatory Markers and in Clinical Periodontal Condition After Non-Surgical Periodontal Treatment in Hypertensive Patients.高血压患者非手术牙周治疗后血清炎症标志物及临床牙周状况的变化
Biomedicines. 2025 Feb 5;13(2):374. doi: 10.3390/biomedicines13020374.
6
Periodontal disease and cardiovascular disease: umbrella review.牙周病与心血管病:伞式综述。
BMC Oral Health. 2024 Oct 28;24(1):1308. doi: 10.1186/s12903-024-04907-1.
7
Periodontitis aggravates COPD through the activation of γδ T cell and M2 macrophage.牙周炎通过激活γδ T细胞和M2巨噬细胞加重慢性阻塞性肺疾病。
mSystems. 2024 Feb 20;9(2):e0057223. doi: 10.1128/msystems.00572-23. Epub 2024 Jan 12.
8
Alterations of oral and gut viromes in hypertension and/or periodontitis.口腔和肠道病毒组在高血压和/或牙周炎中的改变。
mSystems. 2024 Jan 23;9(1):e0116923. doi: 10.1128/msystems.01169-23. Epub 2023 Dec 18.
9
Periodontal Disease and Its Association with Metabolic Syndrome-A Comprehensive Review.牙周病及其与代谢综合征的关系:全面综述。
Int J Mol Sci. 2023 Aug 21;24(16):13011. doi: 10.3390/ijms241613011.
10
Associations Among Tooth Loss, Periodontitis, and Carotid Intima-Media Thickness: the Nagahama Study.牙齿缺失、牙周炎与颈动脉内膜中层厚度的关系:滨名湖研究。
J Atheroscler Thromb. 2023 Oct 1;30(10):1350-1363. doi: 10.5551/jat.63801. Epub 2023 Jan 26.

本文引用的文献

1
Does Periodontal Treatment Help in Arterial Hypertension Control? A Systematic Review of Literature.牙周治疗对控制动脉高血压有帮助吗?文献系统综述
Eur J Dent. 2021 Feb;15(1):168-173. doi: 10.1055/s-0040-1718244. Epub 2020 Oct 8.
2
Global, Regional, and National Levels and Trends in Burden of Oral Conditions from 1990 to 2017: A Systematic Analysis for the Global Burden of Disease 2017 Study.全球、区域和国家层面的口腔疾病负担状况及变化趋势:2017 年全球疾病负担研究的系统分析。
J Dent Res. 2020 Apr;99(4):362-373. doi: 10.1177/0022034520908533. Epub 2020 Mar 2.
3
The global epidemiology of hypertension.高血压的全球流行病学。
Nat Rev Nephrol. 2020 Apr;16(4):223-237. doi: 10.1038/s41581-019-0244-2. Epub 2020 Feb 5.
4
Periodontitis and cardiovascular diseases: Consensus report.牙周炎与心血管疾病:共识报告。
J Clin Periodontol. 2020 Mar;47(3):268-288. doi: 10.1111/jcpe.13189. Epub 2020 Feb 3.
5
Periodontitis is associated with hypertension: a systematic review and meta-analysis.牙周炎与高血压相关:系统评价和荟萃分析。
Cardiovasc Res. 2020 Jan 1;116(1):28-39. doi: 10.1093/cvr/cvz201.
6
Causal association between periodontitis and hypertension: evidence from Mendelian randomization and a randomized controlled trial of non-surgical periodontal therapy.牙周炎与高血压的因果关系:来自孟德尔随机化和非手术牙周治疗随机对照试验的证据。
Eur Heart J. 2019 Nov 1;40(42):3459-3470. doi: 10.1093/eurheartj/ehz646.
7
Systemic effects of periodontitis treatment in patients with type 2 diabetes: a 12 month, single-centre, investigator-masked, randomised trial.牙周炎治疗对 2 型糖尿病患者的全身影响:一项为期 12 个月、单中心、研究者设盲、随机试验。
Lancet Diabetes Endocrinol. 2018 Dec;6(12):954-965. doi: 10.1016/S2213-8587(18)30038-X. Epub 2018 Oct 24.
8
Th1-type immune responses to Porphyromonas gingivalis antigens exacerbate angiotensin II-dependent hypertension and vascular dysfunction.牙龈卟啉单胞菌抗原的 Th1 型免疫应答加重血管紧张素 II 依赖性高血压和血管功能障碍。
Br J Pharmacol. 2019 Jun;176(12):1922-1931. doi: 10.1111/bph.14536. Epub 2018 Dec 26.
9
2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension.2018年欧洲心脏病学会/欧洲高血压学会动脉高血压管理指南:欧洲心脏病学会动脉高血压管理特别工作组和欧洲高血压学会:欧洲心脏病学会动脉高血压管理特别工作组和欧洲高血压学会。
J Hypertens. 2018 Oct;36(10):1953-2041. doi: 10.1097/HJH.0000000000001940.
10
Impact of anti-infective periodontal therapy on parameters of vascular health.牙周抗感染治疗对血管健康参数的影响。
J Clin Periodontol. 2018 Mar;45(3):354-363. doi: 10.1111/jcpe.12849. Epub 2018 Jan 12.

牙周治疗对血压的影响。

Effect of periodontal treatments on blood pressure.

机构信息

State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China.

Department of Stomatology, Nan Chong Central Hospital, Second Clinical Medical College of Chuan Bei Medical College, Nanchong, China.

出版信息

Cochrane Database Syst Rev. 2021 Dec 12;12(12):CD009409. doi: 10.1002/14651858.CD009409.pub2.

DOI:10.1002/14651858.CD009409.pub2
PMID:34897644
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8666138/
Abstract

BACKGROUND

An association has been hypothesized between periodontitis and hypertension. Periodontal therapy is believed to reduce systemic inflammatory mediators and increase endothelial function, thus having the potential to prevent and treat hypertension.

OBJECTIVES

To assess the effect and safety of different periodontal treatment modalities on blood pressure (BP) in people with chronic periodontitis.

SEARCH METHODS

The Cochrane Hypertension Information Specialist searched for randomized controlled trials (RCTs) up to November 2020 in the Cochrane Hypertension Specialised Register, CENTRAL, MEDLINE, Embase, seven other databases, and two clinical trials registries. We contacted the authors of relevant papers regarding further published and unpublished work.

SELECTION CRITERIA

RCTs and quasi-RCTs aiming to detect the effect of periodontal treatment on BP were eligible. Participants should have been diagnosed with chronic periodontitis and hypertension (or no hypertension if the study explored the preventive effect of periodontal treatment). Participants in the intervention group should have undergone subgingival scaling and root planing (SRP) and any other type of periodontal treatments, compared with either no periodontal treatment or alternative periodontal treatment in the control group.

DATA COLLECTION AND ANALYSIS

We used standard methodological procedures expected by Cochrane for study identification, data extraction, and risk of bias assessment. We used a formal pilot-tested data extraction form for data extraction, and the Cochrane risk of bias tool for risk of bias assessment. We planned the meta-analysis, test for heterogeneity, sensitivity analysis, and subgroup analysis. We assessed the certainty of evidence using GRADE. The primary outcome was change in systolic BP (SBP) and diastolic BP (DBP).

MAIN RESULTS

We included eight RCTs. Five had low risk of bias, one had unclear risk of bias, and two had high risk of bias. Four trials compared periodontal treatment with no treatment. We found no evidence of a difference in the short-term change of SBP and DBP for people diagnosed with periodontitis and other cardiovascular diseases except hypertension (very low-certainty evidence). We found no evidence of a difference in long-term changes in SBP (mean difference [MD] -2.25 mmHg, 95% confidence interval [CI] -9.41 to 4.92; P = 0.54; studies = 2, participants = 108; low-certainty evidence) and DBP (MD -2.55 mmHg, 95% CI -6.90 to 1.80; P = 0.25; studies = 2, participants = 103; low-certainty evidence). Concerning people diagnosed with periodontitis, in the short term, two studies of low certainty reported no changes in SBP (MD -0.14 mmHg, 95% CI -4.05 to 3.77; P = 0.94; participants = 294) and DBP (MD -0.15 mmHg, 95% CI -2.47 to 2.17; P = 0.90; participants = 294), and we found no evidence of a difference in SBP and DBP over a long period based on low certainty of evidence. Three studies compared intensive periodontal treatment with supra-gingival scaling. We found no evidence of a difference in changes in SBP and DBP for any length of time in people diagnosed with periodontitis (very low-certainty evidence). In people diagnosed with periodontitis and hypertension, we found one study reporting a significant reduction in the short term in SBP (MD -11.20 mmHg, 95% CI -15.40 to -7.00; P < 0.001; participants = 101; moderate-certainty evidence) and DBP (MD -8.40 mmHg, 95% CI -12.19 to -4.61; P < 0.0001; participants = 101; moderate-certainty evidence).

AUTHORS' CONCLUSIONS: We found no evidence of a difference of an impact of periodontal treatments on BP in most comparisons assessed in this review, and given the low certainty of evidence and the lack of relevant studies we could not draw conclusions about the effect of periodontal treatment on BP in people with chronic periodontitis. We found only one study suggesting that periodontal treatment may reduce SBP and DBP over a short period in people with hypertension and chronic periodontitis, but the certainty of evidence was moderate.

摘要

背景

牙周炎与高血压之间存在关联。牙周治疗被认为可以降低系统性炎症介质并增加内皮功能,从而有可能预防和治疗高血压。

目的

评估不同牙周治疗方法对慢性牙周炎患者血压(BP)的影响和安全性。

检索方法

Cochrane 高血压信息专家在 Cochrane 高血压专业注册库、CENTRAL、MEDLINE、Embase、其他七个数据库和两个临床试验注册库中检索了截至 2020 年 11 月的随机对照试验(RCT)。我们联系了相关论文的作者,了解了进一步的已发表和未发表的研究工作。

选择标准

旨在检测牙周治疗对 BP 影响的 RCT 和准 RCT 符合入选标准。参与者应被诊断为慢性牙周炎和高血压(如果研究探讨牙周治疗的预防作用,则无高血压)。干预组的参与者应接受龈下刮治和根面平整(SRP)和任何其他类型的牙周治疗,与对照组中的无牙周治疗或替代牙周治疗相比。

数据收集和分析

我们使用 Cochrane 预期的标准方法学程序进行研究识别、数据提取和偏倚风险评估。我们使用了经过正式预试验的表格进行数据提取,并使用 Cochrane 偏倚风险工具进行了偏倚风险评估。我们计划进行荟萃分析、异质性检验、敏感性分析和亚组分析。我们使用 GRADE 评估证据的确定性。主要结果是收缩压(SBP)和舒张压(DBP)的变化。

主要结果

我们纳入了八项 RCT。其中五项研究的偏倚风险较低,一项研究的偏倚风险不明确,两项研究的偏倚风险较高。四项试验比较了牙周治疗与无治疗。我们发现,对于除高血压以外的其他心血管疾病(如冠心病)患者,牙周治疗与无治疗相比,在短期和长期内对 SBP 和 DBP 的变化均无差异(非常低确定性证据)。我们发现,对于患有牙周炎的患者,牙周治疗与无治疗相比,在 SBP (MD -2.25mmHg,95%CI -9.41 至 4.92;P = 0.54;研究 = 2,参与者 = 108;低确定性证据)和 DBP (MD -2.55mmHg,95%CI -6.90 至 1.80;P = 0.25;研究 = 2,参与者 = 103;低确定性证据)的长期变化方面,没有证据表明有差异。对于被诊断为牙周炎的患者,两项低确定性证据的研究报告称,短期 SBP (MD -0.14mmHg,95%CI -4.05 至 3.77;P = 0.94;参与者 = 294)和 DBP (MD -0.15mmHg,95%CI -2.47 至 2.17;P = 0.90;参与者 = 294)没有变化,我们没有证据表明在较长时间内 SBP 和 DBP 有差异。三项研究比较了强化牙周治疗与龈上洁治。我们发现,对于任何时间点的患有牙周炎的患者,SBP 和 DBP 的变化均无差异(非常低确定性证据)。在被诊断为牙周炎和高血压的患者中,我们发现一项研究报告称,短期 SBP (MD -11.20mmHg,95%CI -15.40 至 -7.00;P < 0.001;参与者 = 101;中等确定性证据)和 DBP (MD -8.40mmHg,95%CI -12.19 至 -4.61;P < 0.0001;参与者 = 101;中等确定性证据)显著降低。

作者结论

我们发现,在本综述评估的大多数比较中,牙周治疗对 BP 的影响没有差异的证据,而且由于证据确定性低,以及相关研究的缺乏,我们无法得出关于牙周治疗对慢性牙周炎患者 BP 的影响的结论。我们只发现一项研究表明,牙周治疗可能会在短期内降低高血压和慢性牙周炎患者的 SBP 和 DBP,但证据确定性为中等。